Xing Siwei, Ruan Xiaohao, Huang Jingyi, Yan Jiaqi, Lin Wenhao, Huang Jinlun, Liu Jiacheng, Huang Da, Na Rong, Xu Danfeng
Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Division of Urology, Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, People's Republic of China.
Cancer Manag Res. 2022 Aug 30;14:2561-2568. doi: 10.2147/CMAR.S376784. eCollection 2022.
To explore the impact of family history (FH) on renal cell carcinoma (RCC) and its pathological subtype clear cell RCC (ccRCC) in a Chinese population; a significant association has previously been determined not only in familial cancer syndrome but also in sporadic cases in western populations.
Consecutive patients with kidney tumors from October 2017 to May 2021 at a tertiary hospital in Shanghai were enrolled in the study. Demographic and clinical information was collected, including age, gender, FH (positive or negative, types of cancers, degree of relatives, etc.), pathological diagnosis, and Fuhrman grades.
A positive FH of any cancer was observed in 26.5% of the RCC patients, while only 16.8% patients with benign kidney tumor were found to have a positive FH. A strong correlation was observed between FH of any cancers in first-degree relatives and RCC (odds ratio [OR]=4.60, 95% confidence interval [CI]: 1.95-10.85, =5.50×10) or ccRCC (OR=4.63, 95% CI: 1.95-11.02, =9.63×10). In subgroup analysis, FH of digestive cancers was significantly associated with RCC (OR=4.42, 95% CI: 1.35-14.51, =0.005) or ccRCC (OR=4.14, 95% CI: 1.25-13.75, =6.84×10). Similar results were found in multivariate analyses. However, no significant association was observed between FH and age at onset.
FH was an independent risk factor for RCC and ccRCC in this Chinese population. FH of any cancer in first-degree relatives and FH of digestive cancers were found to be the most significant risk factors for kidney cancers.
探讨家族史(FH)对中国人群肾细胞癌(RCC)及其病理亚型透明细胞肾细胞癌(ccRCC)的影响;此前已确定不仅在家族性癌症综合征中,而且在西方人群的散发病例中存在显著关联。
纳入2017年10月至2021年5月在上海一家三级医院连续收治的肾肿瘤患者。收集人口统计学和临床信息,包括年龄、性别、家族史(阳性或阴性、癌症类型、亲属程度等)、病理诊断和富尔曼分级。
26.5%的RCC患者存在任何癌症的家族史阳性,而只有16.8%的良性肾肿瘤患者家族史阳性。一级亲属中任何癌症的家族史与RCC(优势比[OR]=4.60,95%置信区间[CI]:1.95 - 10.85,P = 5.50×10⁻³)或ccRCC(OR = 4.63,95% CI:1.95 - 11.02,P = 9.63×10⁻³)之间存在强相关性。在亚组分析中,消化系统癌症的家族史与RCC(OR = 4.42,95% CI:1.35 - 14.51,P = 0.005)或ccRCC(OR = 4.14,95% CI:1.25 - 13.75,P = 6.84×10⁻³)显著相关。多因素分析中也发现了类似结果。然而,家族史与发病年龄之间未观察到显著关联。
在该中国人群中,家族史是RCC和ccRCC的独立危险因素。一级亲属中任何癌症的家族史以及消化系统癌症的家族史被发现是肾癌最重要的危险因素。